Trexquant Investment LP Kal Vista Pharmaceuticals, Inc. Transaction History
Trexquant Investment LP
- $8.35 Billion
- Q2 2025
A detailed history of Trexquant Investment LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 12,781 shares of KALV stock, worth $145,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,781Holding current value
$145,575% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding KALV
# of Institutions
155Shares Held
55MCall Options Held
1.07MPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$76.6 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$56.4 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$56.3 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$55.7 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$53.2 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $280M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...